摘要
目的评价庆大霉素双氯芬酸钠控制白内障和青光眼术后炎症反应的疗效和安全性。方法采用临床多中心、随仉、双盲、对照试验。试验组和对照组分别滴用庆大霉素双氯芬酸钠和复美新,每日4次,观察2 wk。结果内眼术后试验组和对照组中有效率分别是71.43%和65.52%,两者间的差异无统计学意义。两组的不良事件发生率也无统计学意义。结论庆大霉素双氯芬酸钠是控制内眼术后(白内障手术和青光眼手术)有效和安全的药物。
Purpose To evaluate the efficacy and safety of compound gentamicin didofeuac sodium eyedrops for postoperative inflammation of phacoemulsification and fold lens implantation, as well as trabeculectomy. Methods A multicenter, randomized, double-blind and controlled study was adopted. Compound gentamicin diclofeuac sodium eyedrops and Voltamicin eyedrops, four times each day, were administered in test and control group respectively. All patients were followed up for 14 days. Results The efficacy rates in test and control group were 71.43% and 65.52% respectively in intraocular surgery（include phacoemulsification and anti-glaucoma surgery）. The incidence of adverse reactions in test group and control group is not different statistically. Conclusion Compound gentamicin diclofeuac sodium eyedrops have an excellent efficacy and safety to control the inflammation after phacoemulsification and fold lens implantatian, and trabeculectomy. （Chin J Ophthalmol and Otorhinolaryngology,2006,6：223- 225）
出处
《中国眼耳鼻喉科杂志》
2006年第4期223-225,共3页
Chinese Journal of Ophthalmology and Otorhinolaryngology
作者简介
通讯作者：孙兴怀（E-mail：xhsun@shmu．edu．cn）
